DBV Technologies SA

DBV Technologies announces filing of 2023 Annual Report on Form 10-K and Universal Registration Document

08 Mar 2024 08:33:25 By Nasdaq GlobeNewswire

DBV Technologies Reports Full Year 2023 Financial Results and Business Update

07 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Full Year 2023 Financial Results and Business Update on March 7, 2024

04 Mar 2024 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming AAAAI 2024 Congress

20 Feb 2024 15:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

16 Jan 2024 15:30:00 By Nasdaq GlobeNewswire

Information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2023  

04 Dec 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces 2-Year Results from Ongoing Phase 3 Open-Label Extension to the EPITOPE Trial (EPOPEX) of Viaskin™ Peanut in Toddlers

09 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2023

06 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Present New Data at ACAAI 2023

02 Nov 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Receives Requested Feedback from FDA on Protocol Design Elements for COMFORT Safety Studies and Reports Third Quarter 2023 Financial Results

31 Oct 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Report Third Quarter 2023 Financial Results and Business Update

27 Oct 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Announces Appointment of Virginie Boucinha as Chief Financial Officer

16 Oct 2023 01:00:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

05 Oct 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming Investor Conference

05 Sep 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results

31 Jul 2023 15:25:00 By Nasdaq GlobeNewswire

DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update

25 Jul 2023 15:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

19 Jul 2023 15:30:00 By Nasdaq GlobeNewswire

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

10 Jul 2023 15:30:00 By Nasdaq GlobeNewswire

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023

16 Jun 2023 15:30:00 By Nasdaq GlobeNewswire

DBV Technologies to Participate in Upcoming EAACI Congress 2023

08 Jun 2023 15:30:00 By Nasdaq GlobeNewswire